Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


Peptides Congress 2014

03 Apr 2014 - 04 Apr 2014



Bookmark and Share


Over 400 attendees working within Proteins, Antibodies, Peptides and Biotherapeutics

Over 20 case studies, presentations and panel discussions

Co-Located with our 7th Annual Proteins Congress

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the Peptides Congress taking place on the 3rd & 4th April, 2014 at the Novotel London West, UK. Our esteemed experts will explore recent developments in peptide research from discovery and synthesis through to optimal engineering techniques and therapeutic applications.

The popularity of peptide therapeutics has increased significantly in recent years; the number of new peptides entering the clinic has doubled, and peptide therapies in the US have achieved sales over $1 billion. The Peptides Congress will bring together key decision makers and researchers in this revitalised field. On Day One, the Congress will examine various peptide discovery and synthesis techniques, whilst looking in detail at the design and production of peptide libraries and arrays, as well as synthesised and modified peptides. Our internationally renowned speakers will also give a detailed insight into protein-protein interactions and the production of bioactive peptides.

Due to their compelling potential, many major pharmaceuticals are seeing a resurgence of peptide use in their pipelines. The therapeutic potential of peptides is being embraced by the industry, and offers many novel opportunities for drug discovery. Day Two of the Congress will see discussions focus on peptide engineering, including peptidomimetics and peptide conjugation, as well as cell-penetrating peptides for molecular imaging. Additionally, our experts will discuss the potential of antimicrobial peptides in immunotherapy and as protease inhibitors in drug discovery.


The Peptides Congress is part of the highly successful Oxford Global Proteins Series.

Further information
Scientific News
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!